Ikarian Capital, LLC Inventiva S.A. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.47 - $6.53 $1.02 Million - $1.91 Million	292,599 New	292,599 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$3.69 - $6.05 $8,645 - $14,175	-2,343 Reduced 15.04%	13,236 $48,000
Q1 2022 May 13, 2022	BUY	$10.51 - $13.66 $8,733 - $11,351	831 Added 5.63%	15,579 $178,000
Q3 2021 Nov 15, 2021	SELL	$10.73 - $14.85 $2,703 - $3,742	-252 Reduced 1.68%	14,748 $202,000
Q3 2020 Nov 16, 2020	BUY	$9.87 - $13.42 $148,050 - $201,300	15,000 New	15,000 $177,000

4.85M

Ticker IVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,134,200
Market Cap $99M
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.